← Back to Search

Virtual Group Psychoeducation for Postpartum Depression

N/A
Recruiting
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up completed by parent participants within 2 weeks of attending video group session
Awards & highlights

Study Summary

This trial is testing the feasibility of a virtual group session to help Spanish-speaking parents of newborns/infants learn about postpartum depression and available resources.

Who is the study for?
This trial is for Spanish-speaking mothers of infants under two months old who are attending a participating pediatric practice. It's open to those without any conditions that would prevent them from joining a virtual group session, as determined by clinic staff. Clinic staff facilitating the sessions can also participate.Check my eligibility
What is being tested?
The study is testing a single-session virtual group psychoeducational discussion aimed at educating about postpartum depression and providing resources. The session includes introductions to clinic resources, patient testimonials, discussions on PPD signs and screening procedures, self-care tips, and local support information.See study design
What are the potential side effects?
Since this intervention is educational and supportive in nature rather than medical or pharmaceutical, traditional side effects are not applicable. However, participants may experience emotional discomfort discussing sensitive topics like postpartum depression.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~completed by participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session
This trial's timeline: 3 weeks for screening, Varies for treatment, and completed by participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of intervention Measure
Acceptability of the Intervention as assessed by the Intervention Appropriateness Measure
Feasibility of Intervention Measure
+2 more
Secondary outcome measures
Change in Depression Stigma as assessed by the Adapted Personal Stigma Scale (PSS)
Change in Intention to disclose if developed postpartum depression symptoms as assessed by questionnaire
Change in Postpartum Depression Knowledge as assessed by Adapted Postpartum Depression Knowledge Measure
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention deliveryExperimental Treatment1 Intervention
Participants will receive a 45-60 minute single-session video group psychoeducational intervention delivered by clinic staff.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,262 Previous Clinical Trials
14,823,132 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,785 Previous Clinical Trials
2,689,724 Total Patients Enrolled

Media Library

Single-Session Virtual Group Psychoeducational Session about Postpartum Depression Clinical Trial Eligibility Overview. Trial Name: NCT05423093 — N/A
Postpartum Anxiety Research Study Groups: Intervention delivery
Postpartum Anxiety Clinical Trial 2023: Single-Session Virtual Group Psychoeducational Session about Postpartum Depression Highlights & Side Effects. Trial Name: NCT05423093 — N/A
Single-Session Virtual Group Psychoeducational Session about Postpartum Depression 2023 Treatment Timeline for Medical Study. Trial Name: NCT05423093 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any slots still available for the clinical trial participants?

"Indeed, clinicaltrials.gov reveals that this study is actively searching for participants; it was initially posted on June 9th 2022 and the information has since been updated on June 14th 2022."

Answered by AI

What is the anticipated outcome of this investigation?

"This medical trial will last 6 months and measure the Acceptability of the Intervention as assessed by the Intervention Appropriateness Measure. Secondary objectives include gauging Mental health Service Utilization (Single item, adapted from National Latino and Asian American Study), Change in mental health care stigma as assessed by Stigma Concerns about Mental Health Care (SCMHC) scale, and Change in Postpartum Depression Knowledge as measured through an Adapted Postpartum Depression Knowledge Measure."

Answered by AI

Is it possible for me to be involved in this research?

"This medical research is currently seeking 32 individuals suffering from depression post-partum, aged between 16 and 99. Qualifying criteria include the patient's mother tongue being Spanish, them having given birth to an infant under 2 months of age at a participating practice, and their ability to participate in virtual group sessions without contraindications. Additionally, facilitators for these virtual groups must be sourced from clinic staff."

Answered by AI

What is the current size of the cohort in this clinical trial?

"Confirmed. Clinicaltrials.gov details that this clinical trial, which was published on June 9th 2022, is still recruiting participants for their research project - 32 patients from a single site to be exact."

Answered by AI

Is the age threshold for eligibility in this clinical trial higher than 25?

"This medical trial is seeking participants who are aged 16 years and above, up to the age of 99."

Answered by AI
Recent research and studies
~11 spots leftby Apr 2025